Cluster 645: currently investigational receiving drug eligible patients drugs excluded therapy participation 
Cluster 751: treatments agents concurrent anti use cancer experimental investigational study days 
Cluster 1346: agents anti receiving cancer currently patients eligible investigational study entry 
Cluster 1819: years chemotherapy cancer ages prior treatment completion entry post patients 
Cluster 2162: month entry investigational therapy study prior patients treatment antitumor neoplastic